The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Summer Meeting 2017Join us in Harrogate 23rd to 26th July 2017
Antidepressants and SuicideProf Carmine Pariante attended House of Commons Health Select Committee regarding antidepressants and suicide
Metabolic Guidelines ArticleArticle on the recent metabolic guidelines by Peter Haddad, Gavin Reynolds and Stephen Cooper
Dementia Guidelines MeetingClinical Practice with Anti-Dementia Drugs: Updated Guidelines from the BAP, 19th January 2017
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
New world order: Brexit, drugs and researchLetter to House of Commons Science and Technology Committee
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|26th April 2017||Day A: Schizophrenia / Substance Misuse||Hallam Conference Centre, 44 Hallam Street, London|
|27th April 2017||Day B: Bipolar / Perinatal / ADHD||Hallam Conference Centre, 44 Hallam Street, London|
|28th April 2017||Day C: Depression / Anxiety / Sleep||Hallam Conference Centre, 44 Hallam Street, London|
Antipsychotic medication and weight gain
By Peter Haddad
Posted on 31st March 2017
Introduction This article, written primarily for people with mental health problems and their carers, is about weight gain with antipsychotic medication. Antipsychotics are a group of drugs that are mainly used to treat schizophrenia and manic episodes in bipolar disorder. In both conditions, they are effective in treating symptoms and reducing the risk of a […]
Mind the Brain: How OCD patients get stuck in thoughts and behaviours
By Matilde Vaghi
Posted on 31st March 2017
Most of us think that Obsessive Compulsive Disorder (OCD) is just about fussy tidying. But it’s actually much more serious and it causes sufferers to be locked into obsessions – intrusive, unwanted, thoughts – as well as repetitive, compulsive actions. Sometimes, patients engage in patterns of thinking or behaviour which might seem...
BOOK REVIEW: The Hungry Brain by Dr Stephan Guyenet
By Ravi Das
Posted on 31st March 2017
Since the 1970s there has been an alarming global increase in levels of body fat, to the point where over 60% of adults in The United Kingdom and United States are overweight or obese. This obesity pandemic, along with its associated risks of heart disease, diabetes, stroke, liver disease and cancer represents the great public […]
Can we make cannabis safer?
Tom and co-author Amir talk to Editor Niall Boyce about cannabis harm reduction
1st March 2017
The Emotional Brain: The 14th Oxford Brain Day
Ciara speaks about her work on depression and antidepressants treatments for Oxford Brain Day
25th February 2017
Antidepressants may not be perfect, but they DO save lives
Carmine writes for the Daily Mail showing how, when used correctly, antidepressants do work
21st February 2017
Unexpected deaths of mental health patients in Dorset up 50% in three years
Andrew is interviewed by Bournemouth Echo about increases in unexpected deaths related to mental health
16th February 2017
Why schizophrenia need not rob us of a life in academia
Stephen is interviewed by the Guardian regarding working in academia with a mental illness
1st February 2017
|Professor Carmine Pariante receives PNIRS Norman Cousins Award |
31st March 2017
Prof Carmine Pariante has received the prestigious Norman Cousins Award for outstanding contributions to research in psychoneuroimmunology
|Anti-Dementia Drugs Guidelines Updated |
20th January 2017
The third revision of BAP Guidelines, 'Clinical practice with anti-dementia drugs', are now available for download.
|ACMD report on Diversion and Illicit Supply of Medicines |
19th December 2016
BAP contributed evidence to the ACMD – Diversion & Illicit Supply of Medicines Inquiry
View letter and report
|British Medical Association (BMA) Research Grants 2017 |
16th December 2016
Applications are open 5th December from medical doctors or research scientists working in the UK for BMA research grants.
Most recent articles:
Journal of Psychopharmacology, Volume 31, Issue 4, Page 397-405, April 2017.
Journal of Psychopharmacology, Volume 31, Issue 4, Page 406-417, April 2017.
Journal of Psychopharmacology, Volume 31, Issue 4, Page 418-433, April 2017.
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.